Moderate certaintyPoints to benefit
Clopidogrel to prevent recurrent arterial thromboembolism
FAT CAT, 2015
Appraisal in preparation
Moderate certaintyPoints to benefit
FAT CAT, 2015
Appraisal in preparation
Low certaintyNo benefit shown
Schober et al., 2013
Very low certaintyInconclusive
Very low certaintyInconclusive
RAPACAT, 2023 · FDA FOI summary 141-604, 2025
No evidenceUntested
Low certaintyPoints against
Smith, 2004 · Ployngam, 2006 · Khelik, 2019 · Dutch, 2023